Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

AzurRx BioPharma Inc. (AZRX)

2.62   0.01 (0.38%) 05-17 15:59
Open: 2.62 Pre. Close: 2.61
High: 2.65 Low: 2.56
Volume: 98,020 Market Cap: 52M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 2.653 - 2.666 2.666 - 2.679
Low: 2.522 - 2.538 2.538 - 2.554
Close: 2.59 - 2.616 2.616 - 2.641

Technical analysis

as of: 2019-05-17 4:26:53 PM
Overall:       
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 3.30     One year: 3.62
Support: Support1: 2.37    Support2: 1.97
Resistance: Resistance1: 2.82    Resistance2: 3.10
Pivot: 2.58
Moving Average: MA(5): 2.58     MA(20): 2.57
MA(100): 2.20     MA(250): 2.39
MACD: MACD(12,26): 0.05     Signal(9): 0.06
Stochastic oscillator: %K(14,3): 29.96     %D(3): 27.35
RSI: RSI(14): 54.85
52-week: High: 3.75  Low:   Change(%): 0.8
Average Vol(K): 3-Month: 9503  10-Days: 14205

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
AZRX has closed below upper band by 41.1%. Bollinger Bands are 40.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to AZRX's normal range. The bands have been in this narrow range for 5 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 05 Jul 2018 20:29:30 Z
Health Care Sector Update for 07/05/2018: CLVS,APOP,AZRX,ZYNE

Thu, 05 Jul 2018 18:29:22 Z
Health Care Sector Update for 07/05/2018: ZYNE,APOP,AZRX

Thu, 05 Jul 2018 13:49:35 Z
Health Care Sector Update for 07/05/2018: APOP,RLM,AZRX

Wed, 12 Oct 2016 14:17:56 Z
AzurRX Biopharma prices downsized $5 million IPO at lowered price of $5.50

Wed, 05 Oct 2016 14:43:30 Z
Gastrointestinal biotech AzurRX Biopharma decreases proposed IPO deal size

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency NA
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 19.83
Shares Float (M) 18.90
% Held by Insiders
% Held by Institutions 15.80
Shares Short (K)
Shares Short P. Month (K)

Stock Financials

EPS
EPS Est. Current Year -0.850
EPS Est. Next Year -0.670
EPS Est. Next Quarter -0.160
Forward EPS -0.640
Book Value (p.s.) 11.970
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm) -212.9
Return on Equity (ttm) -446.4
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M) -10.87
Levered Free Cash Flow (M) -6.37

Stock Valuations

P/E
P/E Growth Ratio
P/BV 0.22
P/S
P/CF -4.78

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.